EPISODE · Nov 29, 2017 · 16 MIN
ANZUP 2017 Interviews - David Quinn
from Talking Urology Podcast · host Talking Urology
David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
What this episode covers
David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
NOW PLAYING
ANZUP 2017 Interviews - David Quinn
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m